Medicare Enrolled

Dr. Gregory Parr, M.D.

Urology Physician · Ormond Beach, FL
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Speaking/Promotional
300 CLYDE MORRIS BLVD, Ormond Beach, FL 32174
3866735100
In practice since 2006 (19 years)
NPI: 1194765495 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Parr from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Parr? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Parr

Dr. Gregory Parr is an urology physician in Ormond Beach, FL, with 19 years in practice. Based on federal Medicare data, Dr. Parr performed 78,436 Medicare services across 8,699 unique beneficiaries.

Between the years covered by Open Payments, Dr. Parr received a total of $22,194 from 40 pharmaceutical and/or device companies across 250 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Parr is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice▲ Top 1% volume in FL$ $22,194 industry payments

Medicare Practice Summary

Medicare Utilization ↗
78,436
Medicare services
Top 1% in FL for urology physician
8,699
Unique beneficiaries
$8
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~4,128 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Testosterone injection51,004$0$0
Contrast dye for imaging (iodine-based)8,600$0$0
Creatinine test (kidney function)3,187$5$25
Automated urinalysis3,181$2$10
Infectious disease DNA/RNA test2,938$34$86
Office visit, established patient (20-29 min)1,518$64$215
Bladder ultrasound after voiding1,237$7$200
Office visit, established patient (30-39 min)1,174$85$325
Blood draw (venipuncture)745$8$10
Yeast/candida DNA test711$34$81
Detection test by nucleic acid for multiple organisms, amplified probe(s) technique569$69$82
Electronic assessment of bladder emptying313$9$275
Drug injection, under skin or into muscle303$10$75
Principal care management services for a single high-risk disease, first 30 minutes of clinical staff time directed by health care professional, per calendar month301$48$376
Detection test by nucleic acid for staphylococcus aureus (bacteria), amplified probe technique226$35$84
Detection test by nucleic acid for strep (streptococcus, group b), amplified probe technique223$35$85
Detection test by nucleic acid for vancomycin resistance strep (vre), amplified probe technique208$34$83
New patient office visit (45-59 min)207$117$600
Insertion of lower leg neurostimulator electrode174$85$500
X-ray of abdomen, 1 view159$22$130
Ceftriaxone antibiotic injection109$0$50
Ct scan of abdomen and pelvis without contrast103$144$850
Imaging of urinary tract following injection of a contrast agent98$19$205
Chronic care management, first 20 min/month90$49$154
Ct scan of abdomen and pelvis before and after contrast86$266$1,200
Injection, garamycin, gentamicin, up to 80 mg84$2$25
Insertion of implant in urethra within prostate gland using an endoscope, each additional implant82$40$1,000
Principal care management services for a single high-risk disease, each additional 30 minutes of clinical staff time directed by health care professional, per calendar month71$37$402
Office visit, established patient (10-19 min)62$40$150
Diagnostic exam of bladder and urethra using an endoscope54$180$470
Instillation of anti-cancer drug into bladder51$65$500
Insertion of tube into ureter using an endoscope through bladder area43$98$450
Insertion of device into abdomen with pressure and urine flow rate study41$147$555
Catheterization for collection of specimen, single patient, all places of service35$8$10
Dilation of urethra using an endoscope34$118$1,470
Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings33$25$600
New patient office visit (30-44 min)33$81$300
Chronic care management, additional 20 min/month29$37$116
Insertion of implant in urethra within prostate gland using an endoscope, 1 implant28$166$1,500
Complete ultrasound scan behind abdominal cavity28$79$275
Biopsy of prostate gland27$101$500
Office visit, established patient, complex (40-54 min)27$127$440
Complex measurement of pressure of urine flow in bladder with voiding pressure studies23$279$800
Injection of biodegradable material next to prostate21$130$750
Ultrasound scan of pelvic region through rectum21$25$288
Insertion of sacral nerve neurostimulator electrode array20$315$1,213
Complex measurement of pressure of urine flow in bladder with urethra pressure and voiding pressure studies19$297$1,000
Needle biopsy of prostate gland using image guidance19$292$800
Limited ultrasound scan behind abdominal cavity19$42$200
Shock wave crushing of kidney stones17$446$3,040
Destruction of growth of bladder and urethra using an endoscope, less than 0.5 cm13$137$2,300
Exam with injections of chemical for destruction of bladder using an endoscope13$130$500
Ultrasonic guidance for needle placement13$24$287
Destruction and/or removal of growth of bladder and urethra using an endoscope, 2.0-5.0 cm12$218$1,564
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$22,194
Total received (2018-2024)
Avg $3,171/year across 7 years
Top 10% in FL for urology physician
40
Companies
250
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$15,452 (69.6%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$6,742 (30.4%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$434
2023
$646
2022
$1,501
2021
$1,390
2020
$636
2019
$7,365
2018
$10,221

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Astellas Pharma US Inc
$15,713
NeoTract Inc.
$1,976
Axonics, Inc.
$1,351
Teleflex LLC
$486
PFIZER INC.
$308
Palette Life Sciences, Inc.
$214
Axonics Modulation Technologies, Inc.
$182
Sumitomo Pharma America, Inc.
$172
Cook Medical LLC
$166
UROVANT SCIENCES INC
$159
HealthTronics Mobile Solutions, LLC
$144
ABBVIE INC.
$135
Boston Scientific Corporation
$115
Allergan Inc.
$99
Myriad Genetic Laboratories, Inc.
$95
Allergan, Inc.
$89
Avadel Specialty Pharmaceuticals, LLC
$82
Coloplast Corp
$65
Myovant Sciences Inc.
$56
TOLMAR Pharmaceuticals, Inc.
$55
Medtronic, Inc.
$48
Tolmar, Inc.
$47
Amgen Inc.
$46
COLOPLAST CORP
$43
Rochester Medical Corporation
$40
Antares Pharma, Inc.
$37
Aytu BioScience, Inc
$35
Verity Pharmaceuticals Inc.
$31
AbbVie, Inc.
$29
AMAG Pharmaceuticals, Inc.
$23
Bayer Healthcare Pharmaceuticals Inc.
$22
Blue Earth Diagnostics Limited
$20
Endo Pharmaceuticals Inc.
$18
Ferring Pharmaceuticals Inc.
$17
Zyla Life Sciences
$16
Olympus America Inc.
$15
180 Medical, Inc.
$14
Zyla Life Sciences, Inc.
$13
Janssen Biotech, Inc.
$11
Clarus Therapeutics Inc.
$6
Top 3 companies account for 85.8% of total payments
Associated products mentioned in payments ›
Androgel · Axonics · Axonics r-SNM System · Axumin · BOTOX · BOTOX THERAPEUTIC · Bulkamid · CONTINENCE CARE · COOK · COOK MEDICAL HOLMIUM LASER FIBER · Cook · ELIGARD · Erleada · GEMTESA · GENERAL THERAPIES · GENTLECATH · GREENLIGHT · INTERSTIM · INTRAROSA · JATENZO · LITHOVUE · LUPRON DEPOT · MIRABEGRON · MYRBETRIQ · Mobile Cryoblation Services · Myrbetriq · NOCDURNA · Natesto · Noctiva · Nubeqa · ORGOVYX · OTREXUP · PREMARIN · PROLARIS · Prolia · ReTrace · SPEEDICATH · SPRIX · SpaceOAR VUE System - 10mL · SpeediCath · TITAN · Trelstar · UROLIFT · UroLift · UroLift System · VESICARE · XIAFLEX · XTANDI · Xtandi · ZORVOLEX · iTIND System
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (70%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in urology physician and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 10% for urology physician in FL.

Equivalent to $28 per 100 Medicare services performed
Looking for a urology physician in Ormond Beach?
Compare urology physicians in the Ormond Beach area by procedure volume, costs, and industry payment transparency.
Browse urology physicians nearby

Geographic Context

Urology Physicians within 10 mi
30
Per 100K population
5.3
County median income
$66,581
Nearest hospital
ADVENTHEALTH DAYTONA BEACH
6.9 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Parr is a mixed practice specialist, with above-average Medicare volume (top 1% in FL), and high industry engagement (speaking/promotional, top 10%), with 19 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Parr experienced with testosterone injection?
Based on Medicare claims data, Dr. Parr performed 51,004 testosterone injection services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Parr receive payments from pharmaceutical companies?
Yes. Dr. Parr received a total of $22,194 from 40 companies across 250 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Parr's costs compare to other urology physicians in Ormond Beach?
Dr. Parr's average Medicare payment per service is $8. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Parr) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →